株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

セリアック病 (CD) の世界市場の分析と予測

Global Celiac Disease Market Research and Forecast 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 637945
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.49円で換算しております。
セリアック病 (CD) の世界市場の分析と予測 Global Celiac Disease Market Research and Forecast 2018-2023
出版日: 2018年04月18日 ページ情報: 英文
概要

当レポートでは、世界のセリアック病 (診断薬・治療薬) の市場について分析し、疾患の概要や市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、診断方法別・エンドユーザー別・地域別の市場動向の見通し (今後7年間分)、最新の市場競争状況、主要企業のプロファイルなどを調査しております。

第1章 分析概要

第2章 市場の概略と考察

  • 定義
  • アナリストの見解と現在の市場動向
    • 分析のポイント
    • 提言
    • 結論
  • 世界各国の規制状況 (米国、欧州、中国、インドなど)

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場区分

  • 世界のセリアック病市場:診断方法別
    • 血清検査
    • 遺伝子検査
    • 小腸生検
  • 世界のセリアック病市場:エンドユーザー別
    • 病院・診断センター
    • 研究機関

第5章 競争環境

  • 市場戦略の分析
  • 主要企業の分析
  • パイプライン製品の分析

第6章 地域別分析

  • 北米市場 (米国、カナダ)
  • 欧州市場 (英国、ドイツ、イタリア、スペイン、フランスなど)
  • アジア太平洋地域市場 (インド、中国、日本など)
  • 他の国々 (RoW) の市場

第7章 企業プロファイル

  • ABBOTT LABORATORIES, INC.
  • ABBVIE INC.
  • ACTOGENIX N.V.
  • ADMA BIOLOGICS, INC.
  • ALBA THERAPEUTICS CORPORATION
  • ALVINE PHARMACEUTICALS, INC.
  • AMGEN INC
  • AVAXIA BIOLOGICS, INC.
  • BAYER AG
  • BIO RAD LABORATORIES INC.
  • BIOLINERX LTD
  • BRISTOL-MYERS SQUIBB
  • BTG PLC
  • CELGENE CORPORATION
  • CHEMOCENTRYX INC
  • ELI LILLY AND COMPANY
  • GLAXOSMITHKLINE PLC
  • IMMUSANT, INC.
  • JANSSEN PHARMACEUTICALS
  • JOHNSON & JOHNSON
  • MERCK & CO INC (MERCK SHARP & DOHME CORP)
  • SANOFI S.A
  • THERMO FISHER SCIENTIFIC, INC
図表

List of Tables

  • TABLE # 1 GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL SEROLOGIC TEST MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL HOSPITALS AND DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • TABLE # 7 NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 8 NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2017-2023 ($ MILLION)
  • TABLE # 9 NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
  • TABLE # 10 EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 11 EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2017-2023 ($ MILLION)
  • TABLE # 12 EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
  • TABLE # 13 APAC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 14 APAC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2017-2023 ($ MILLION)
  • TABLE # 15 APAC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
  • TABLE # 16 ROW CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2017-2023 ($ MILLION)
  • TABLE # 17 ROW CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL CELIAC DISEASE MARKET SHARE BY DIAGNOSTIC TYPE, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL CELIAC DISEASE MARKET SHARE BY END USERS, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL CELIAC DISEASE MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 4 NORTH AMERICA CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 5 US CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 EUROPEAN CELIAC DISEASE MARKET SIZE, 2017-2023 (4MILLION)
  • FIGURE # 8 UK CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 FRANCE CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 GERMANY CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 ITALY CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 SPAIN CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 ROE CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 ASIA PACIFIC CELIAC DISEASE MARKET SIZE, 2017-2023 ($MILLION)
  • FIGURE # 15 INDIA CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 CHINA CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 JAPAN CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 18 ROAPAC CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 19 REST OF THE WORLD CELIAC DISEASE MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2018269

Celiac disease market is an autoimmune disorder caused by the exposure to dietary gluten and damage inner lining of the small intestine. The disease can contribute to several diseases and disorders such as neurological disorder, infertility, low bone density, and certain cancers. There are presently no drugs available for the treatment of celiac disease. It can only be treated by consuming gluten-free diet. The expected launch of Alba/Teva's larazotide acetate in the US in 2018 and in 5EU in 2019, and the launch of Alvine/AbbVie's latiglutenase in the US in 2019 and in 5EU in 2020 are considered to fuel the market growth in the celiac disease market. These drugs are anticipated to target patients who undergo gluten exposure.

One of the major factors that is contributing in the market growth is organization of various awareness programs and initiatives taken by the government in different countries for the treatment of celiac disease. The government with such initiatives could strongly boost the market growth. In addition, various funds are offered to research and development activities that is further accelerating the market growth. For example, in Italy, children and adults are tested for celiac disease when they have specific symptoms. Vouchers are given to the diagnosed celiacs for buying specifically produced gluten free foods, up to $168 per month. Moreover, the Italian Celiac Association and government educates restaurants on how to deal with celiac disease. There are even gluten-free meals provided in hospitals, schools, and all other public eating establishments.

The global celiac disease market is analysed on the basis of geographical regions that are contributing significantly to the growth of the market. North America is estimated to be the dominating region in the global celiac disease market. Increasing patient pool in the region owing to increase in consumption of gluten-containing food is one of the major factors that is accelerating the growth of the market in North America.

The companies present actively in the global celiac disease market are Abbott Laboratories, Eli Lilly & Co, Novartis AG, Johnson & Johnson, Alvine Pharmaceuticals Inc., and so on.

Research Methodology:

The market study of celiac disease market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue
  • Supplier Websites such as Alibaba, amazon for pricing analysis

The report is intended for hospitals, diagnostics laboratories and research institutes for overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:

1. Global celiac disease market by diagnostic type

2. Global celiac disease market by end users

THE REPORT COVERS:

  • Comprehensive research methodology of Global Celiac Disease Market.
  • This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Celiac Disease Market.
  • Insights about market determinants which are stimulating the Global Celiac Disease Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

CHAPTER 1. REPORT SUMMARY

  • 1.1. RESEARCH METHODS AND TOOLS
  • 1.2. MARKET BREAKDOWN
    • 1.2.1. BY SEGMENTS
    • 1.2.2. BY GEOGRAPHY
    • 1.2.3. BY STAKEHOLDERS

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS

  • 2.1. DEFINITION
  • 2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
    • 2.2.1. KEY FINDINGS
    • 2.2.2. RECOMMENDATION
    • 2.2.3. CONCLUSION
  • 2.3. REGULATIONS
      • 2.3.1.1. UNITED STATES
      • 2.3.1.2. EUROPEAN UNION
      • 2.3.1.3. CHINA
      • 2.3.1.4. INDIA

CHAPTER 3. MARKET DETERMINANTS

  • 3.1. MOTIVATORS
    • 3.1.1. PREVALENCE OF CELIAC DISEASES
    • 3.1.2. GOVERNMENT INITIATIVES AND AWARENESS PROGRAMS SUCH AS CELIAC DISEASE AWARENESS CAMPAIGN AND CELIAC DISEASE SCREENING PROGRAM
    • 3.1.3. INORGANIC GROWTH STRATEGIES SUCH AS MERGER & ACQUISITION
    • 3.1.4. HIGH CONSUMPTION OF GLUTEN-CONTAINING FOOD SUCH AS BREAD, COKE, BEER AND PIZZA.
    • 3.1.5. RISING HEALTHCARE EXPENDITURE IN DEVELOPED REGIONS
  • 3.2. RESTRAINT
    • 3.2.1. HIGH COST OF GLUTEN-FREE FOOD
    • 3.2.2. GLUTEN FREE DIET BEING THE ONLY TREATMENT METHOD AVAILABLE
  • 3.3. OPPORTUNITY
    • 3.3.1. ROBUST PIPELINE FOR CELIAC DISEASE DRUGS

CHAPTER 4. MARKET SEGMENTATION

  • 4.1. GLOBAL CELIAC DISEASE MARKET BY DIAGNOSTIC TYPE
    • 4.1.1. SEROLOGIC TEST
    • 4.1.2. GENETIC TESTING
    • 4.1.3. SMALL-BOWEL BIOPSY
  • 4.2. GLOBAL CELIAC DISEASE MARKET BY END USERS
    • 4.2.1. HOSPITALS AND DIAGNOSTIC CENTERS
    • 4.2.2. RESEARCH INSTITUTES

CHAPTER 5. COMPETITIVE LANDSCAPE

  • 5.1. MARKET STRATEGY ANALYSIS
  • 5.2. KEY COMPANY ANALYSIS
  • 5.3. PIPELINE ANALYSIS

CHAPTER 6. REGIONAL ANALYSIS

  • 6.1. NORTH AMERICAN
    • 6.1.1. UNITED STATES
    • 6.1.2. CANADA
  • 6.2. EUROPE
    • 6.2.1. U.K
    • 6.2.2. GERMANY
    • 6.2.3. ITALY
    • 6.2.4. SPAIN
    • 6.2.5. FRANCE
    • 6.2.6. ROE
  • 6.3. ASIA PACIFIC
    • 6.3.1. INDIA
    • 6.3.2. CHINA
    • 6.3.3. JAPAN
    • 6.3.4. ROAPAC
  • 6.4. REST OF THE WORLD

CHAPTER 7. COMPANY PROFILES

  • 7.1. ABBOTT LABORATORIES, INC.
  • 7.2. ABBVIE INC.
  • 7.3. ACTOGENIX N.V.
  • 7.4. ADMA BIOLOGICS, INC.
  • 7.5. ALBA THERAPEUTICS CORPORATION
  • 7.6. ALVINE PHARMACEUTICALS, INC.
  • 7.7. AMGEN INC
  • 7.8. AVAXIA BIOLOGICS, INC.
  • 7.9. BAYER AG
  • 7.10. BIO RAD LABORATORIES INC.
  • 7.11. BIOLINERX LTD
  • 7.12. BRISTOL-MYERS SQUIBB
  • 7.13. BTG PLC
  • 7.14. CELGENE CORPORATION
  • 7.15. CHEMOCENTRYX INC
  • 7.16. ELI LILLY AND COMPANY
  • 7.17. GLAXOSMITHKLINE PLC
  • 7.18. IMMUSANT, INC.
  • 7.19. JANSSEN PHARMACEUTICALS
  • 7.20. JOHNSON & JOHNSON
  • 7.21. MERCK & CO INC (MERCK SHARP & DOHME CORP)
  • 7.22. SANOFI S.A
  • 7.23. THERMO FISHER SCIENTIFIC, INC